Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Arginine-cysteine polymorphism at codon 264 of the human CYP19 gene does not affect aromatase activity.

Literature DB >> 9352581

Arginine-cysteine polymorphism at codon 264 of the human CYP19 gene does not affect aromatase activity.

J Watanabe¹, N Harada, K Suemasu, Y Higashi, O Gotoh, K Kawajiri.

Abstract

Entities: Chemical Gene Species

Mesh：

Substances：

Year: 1997 PMID： 9352581 DOI： 10.1097/00008571-199710000-00014

Source DB: PubMed Journal: Pharmacogenetics ISSN： 0960-314X

Keyword Cloud
Cited

× No keyword cloud information.

10 in total

Review 1. Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility.

Authors: M M de Jong; I M Nolte; G J te Meerman; W T A van der Graaf; J C Oosterwijk; J H Kleibeuker; M Schaapveld; E G E de Vries
Journal: J Med Genet Date: 2002-04 Impact factor: 6.318

2. CYP19A1 polymorphisms and clinical outcomes in postmenopausal women with hormone receptor-positive breast cancer in the BIG 1-98 trial.

Authors: Brian Leyland-Jones; Kathryn P Gray; Mark Abramovitz; Mark Bouzyk; Brandon Young; Bradley Long; Roswitha Kammler; Patrizia Dell'Orto; Maria Olivia Biasi; Beat Thürlimann; Maria B Lyng; Henrik J Ditzel; Vernon J Harvey; Patrick Neven; Isabelle Treilleux; Birgitte Bruun Rasmussen; Rudolf Maibach; Karen N Price; Alan S Coates; Aron Goldhirsch; Olivia Pagani; Giuseppe Viale; James M Rae; Meredith M Regan
Journal: Breast Cancer Res Treat Date: 2015-05-03 Impact factor: 4.872

3. Genetic variation in estrogen and progesterone pathway genes and breast cancer risk: an exploration of tumor subtype-specific effects.

Authors: Sarah J Nyante; Marilie D Gammon; Jay S Kaufman; Jeannette T Bensen; Dan Yu Lin; Jill S Barnholtz-Sloan; Yijuan Hu; Qianchuan He; Jingchun Luo; Robert C Millikan
Journal: Cancer Causes Control Date: 2014-11-25 Impact factor: 2.506

4. Hormone receptor-related gene polymorphisms and prostate cancer risk in North Indian population.

Authors: Khadijeh Onsory; R C Sobti; Adnan Issa Al-Badran; Masatoshi Watanabe; Taizo Shiraishi; Awtar Krishan; Harsh Mohan; Pushpinder Kaur
Journal: Mol Cell Biochem Date: 2008-05-16 Impact factor: 3.396

5. Haplotype analyses of CYP19A1 gene variants and breast cancer risk: results from the Shanghai Breast Cancer Study.

Authors: Qiuyin Cai; Nobuhiko Kataoka; Chun Li; Wanqing Wen; Jeffrey R Smith; Yu-Tang Gao; Xiao Ou Shu; Wei Zheng
Journal: Cancer Epidemiol Biomarkers Prev Date: 2008-01 Impact factor: 4.254

6. Functional genetic polymorphisms in the aromatase gene CYP19 vary the response of breast cancer patients to neoadjuvant therapy with aromatase inhibitors.

Authors: Liewei Wang; Katarzyna A Ellsworth; Irene Moon; Linda L Pelleymounter; Bruce W Eckloff; Yvette N Martin; Brooke L Fridley; Gregory D Jenkins; Anthony Batzler; Vera J Suman; Saranya Ravi; J Michael Dixon; William R Miller; Eric D Wieben; Aman Buzdar; Richard M Weinshilboum; James N Ingle
Journal: Cancer Res Date: 2010-01-01 Impact factor: 12.701

7. A non-synonymous coding change in the CYP19A1 gene Arg264Cys (rs700519) does not affect circulating estradiol, bone structure or fracture.

Authors: Jenny Z Wang; Mandeep S Deogan; Joshua R Lewis; Shelby Chew; Ben H Mullin; Tegan J McNab; Scott G Wilson; Evan Ingley; Richard L Prince
Journal: BMC Med Genet Date: 2011-12-20 Impact factor: 2.103